Skip to content
10-Q

Quarterly Report

SCOPUS BIOPHARMA INC.

0001410578-22-002634

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 12, 2022 21.09M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $1.16M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $7.94M
Stockholders Equity Q2 2022 · Jun 30, 2022 −$3.7M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$530.43K
Stockholders Equity Q2 2022 · Dec 31, 2021 $4.02M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$1.98M
Stockholders Equity Q2 2022 · Mar 31, 2021 $4.15M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$1.83M
Current Assets Q2 2022 · Jun 30, 2022 $1.67M
Current Assets Q2 2022 · Dec 31, 2021 $8.18M
Total Assets Q2 2022 · Jun 30, 2022 $1.67M
Total Assets Q2 2022 · Dec 31, 2021 $8.19M
Operating Income Q2 2022 · Jun 30, 2022 −$3.32M
Operating Income Q2 2022 · Jun 30, 2022 −$7.98M
Operating Income Q2 2022 · Jun 30, 2021 −$15.28M
Operating Income Q2 2022 · Jun 30, 2021 −$18.36M
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $0
Net Income Q2 2022 · Mar 31, 2022 −$4.66M
Net Income Q2 2022 · Jun 30, 2021 −$15.63M
Net Income Q2 2022 · Jun 30, 2021 −$19.03M
Net Income Q2 2022 · Mar 31, 2021 −$3.41M
Shares Diluted Q2 2022 · Jun 30, 2021 16.19M sh
Shares Diluted Q2 2022 · Jun 30, 2021 15.77M sh
Capex Q2 2022 · Jun 30, 2021 $0
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$4.76M
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.97
Eps Diluted Q2 2022 · Jun 30, 2021 −$1.21
Eps Basic Q2 2022 · Jun 30, 2021 −$0.97
Eps Basic Q2 2022 · Jun 30, 2021 −$1.21
Sga Expense Q2 2022 · Jun 30, 2021 $1.73M
Sga Expense Q2 2022 · Jun 30, 2021 $3.55M
Rd Expense Q2 2022 · Jun 30, 2021 $13.56M
Rd Expense Q2 2022 · Jun 30, 2021 $14.81M